Erythropoietic agents in peritoneal dialysis.
Muirhead
Norman
N
University of Western Ontario, London, Ontario, Canada. norman.muirhead@lhsc.on.ca
D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D015314:Dialysis Solutions; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D010530:Peritoneal Dialysis / Q000379:methods*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D015314:Dialysis Solutions; D006397:Hematinics; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D000068817:Epoetin Alfa